Stockscreener 앱 받기
12.85
1.31%
-0.17
시간 외 거래:
13.10
0.25
+1.95%
전일 마감가:
$13.02
열려 있는:
$13.18
하루 거래량:
1.37M
Relative Volume:
0.69
시가총액:
$1.96B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-9.5896
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
-2.50%
1개월 성능:
+16.29%
6개월 성능:
+60.02%
1년 성능:
+195.40%
1일 변동 폭
$12.52
$13.21
1주일 범위
$12.52
$13.25
52주 변동 폭
$3.981
$13.52
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
12.85 | 1.98B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
How high can Adaptive Biotechnologies Corporation stock goWeekly Stock Analysis & AI Driven Stock Movement Reports - Newser
Has Adaptive Biotechnologies Corporation found a price floorGDP Growth & Step-by-Step Trade Execution Guides - Newser
Hsbc Holdings PLC Has $256,000 Position in Adaptive Biotechnologies Corporation $ADPT - Defense World
How to recover losses in Adaptive Biotechnologies Corporation stockBull Run & Weekly High Potential Stock Alerts - Newser
Multi asset correlation models including Adaptive Biotechnologies CorporationGlobal Markets & High Win Rate Trade Alerts - Newser
Real time scanner hits for Adaptive Biotechnologies Corporation explainedWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-09-04 04:55:57 - Newser
What high frequency data says about Adaptive Biotechnologies Corporation2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
Should you wait for a breakout in Adaptive Biotechnologies CorporationMarket Trend Review & Smart Allocation Stock Reports - Newser
Has Adaptive Biotechnologies Corporation formed a bullish divergence2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-09-03 06:26:44 - Newser
Visualizing Adaptive Biotechnologies Corporation stock with heatmapsJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Custom watchlist performance reports with Adaptive Biotechnologies Corporation2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationMarket Growth Summary & Short-Term Trading Opportunity Alerts - Newser
Candlestick signals on Adaptive Biotechnologies Corporation stock todayJobs Report & AI Forecast Swing Trade Picks - Newser
Developing predictive dashboards with Adaptive Biotechnologies Corporation data2025 Technical Patterns & Technical Confirmation Alerts - Newser
Is Adaptive Biotechnologies Corporation a top pick in the sectorMarket Risk Report & High Accuracy Swing Trade Signals - خودرو بانک
Does Adaptive Biotechnologies Corporation stock reflect fundamentalsWeekly Trade Summary & Reliable Price Action Trade Plans - خودرو بانک
Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice - Yahoo Finance
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesTrade Volume Report & Daily Entry Point Alerts - Newser
Regression analysis insights on Adaptive Biotechnologies Corporation performance2025 Support & Resistance & Long-Term Safe Return Strategies - Newser
Will Adaptive Biotechnologies Corporation rebound enough to break evenJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Published on: 2025-08-30 22:39:14 - Newser
Published on: 2025-08-30 15:15:44 - Newser
Market reaction to Adaptive Biotechnologies Corporation’s recent news2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Is it time to cut losses on Adaptive Biotechnologies CorporationQuarterly Growth Report & AI Driven Stock Reports - Newser
Price momentum metrics for Adaptive Biotechnologies Corporation explainedPortfolio Risk Summary & Low Risk Entry Point Tips - Newser
Published on: 2025-08-29 12:14:22 - Newser
Published on: 2025-08-29 11:39:06 - Newser
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Is Adaptive Biotechnologies Corporation stock ready for a breakoutJuly 2025 Short Interest & Growth Focused Entry Reports - Newser
Published on: 2025-08-29 12:12:27 - Newser
Invesco Ltd. Has $4.11 Million Stock Position in Adaptive Biotechnologies Corporation $ADPT - Defense World
Russell Investments Group Ltd. Raises Stock Position in Adaptive Biotechnologies Corporation $ADPT - Defense World
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adaptive Biotechnologies Corp 주식 (ADPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Option Exercise |
6.32 |
68,412 |
432,364 |
1,347,936 |
| ROBINS HARLAN S | Chief Scientific Officer |
May 01 '25 |
Sale |
7.35 |
68,412 |
502,828 |
1,279,524 |
1.40%
자본화:
|
볼륨(24시간):